bevantolol has been researched along with Liver Cirrhosis in 1 studies
bevantolol: structure given in first source
bevantolol : A propanolamine that is 3-aminopropane-1,2-diol in which the hydrogen of the primary hydroxy group is substituted by 3-methylphenyl and one of the hydrogens attached to the nitrogen is substituted by 2-(3,4-dimethoxyphenyl)ethyl. A beta1 adrenoceptor antagonist, it has been shown to be as effective as other beta-blockers for the treatment of angina pectoris and hypertension.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bevantolol is a new, cardioselective beta-receptor antagonist that undergoes extensive hepatic biotransformation." | 1.27 | Bevantolol disposition in patients with hepatic cirrhosis. ( Lawand, S; Matthews, C; McCans, J; Nattel, S, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nattel, S | 1 |
| Lawand, S | 1 |
| Matthews, C | 1 |
| McCans, J | 1 |
1 other study available for bevantolol and Liver Cirrhosis
| Article | Year |
|---|---|
Bevantolol disposition in patients with hepatic cirrhosis.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Chromatography, High Pressure Liquid; Half-Life; | 1987 |